机译:初级抗真预防:侵袭性真菌疾病发病率降低以及血液学患者危险因素减少了5年的回顾性研究
Department of Hematology and BMT CenterChinese PLA General HospitalBeijing China;
Department of Hematology and BMT CenterChinese PLA General HospitalBeijing China;
Department of Hematology and BMT CenterChinese PLA General HospitalBeijing China;
Department of Hematology and BMT CenterChinese PLA General HospitalBeijing China;
Department of Hematology and BMT CenterChinese PLA General HospitalBeijing China;
Department of Hematology and BMT CenterChinese PLA General HospitalBeijing China;
Department of Hematology and BMT CenterChinese PLA General HospitalBeijing China;
Department of Hematology and BMT CenterChinese PLA General HospitalBeijing China;
Department of Hematology and BMT CenterChinese PLA General HospitalBeijing China;
Department of Hematology and BMT CenterChinese PLA General HospitalBeijing China;
Department of Hematology and BMT CenterChinese PLA General HospitalBeijing China;
Department of Hematology and BMT CenterChinese PLA General HospitalBeijing China;
primary antifungal prophylaxis; invasive fungal disease; haematological malignancies; risk factors;
机译:初级抗真预防:侵袭性真菌疾病发病率降低以及血液学患者危险因素减少了5年的回顾性研究
机译:泊沙康唑的预防-对血液病患者侵袭性真菌疾病和抗真菌药物治疗的影响
机译:posaconazole预防 - 影响侵袭性真菌疾病发病率和血液神学患者的抗真菌治疗
机译:禁忌共患病的发生及其风险因素:来自韩国教学医院的回顾性观察研究
机译:比较40岁以下的患者和40岁以上进行冠状动脉搭桥术的患者的术前选择的冠心病危险因素。
机译:与氟康唑预防相比泊沙康唑可减少侵袭性真菌病但对泊沙康唑的总体生存没有影响:一项针对急性髓样白血病/骨髓增生异常综合症接受诱导治疗的患者的回顾性队列研究
机译:侵袭性真菌突破感染,真菌定植和抗性患者的抗性菌株的出现接受抗真菌患者与皮萨基唑唑(Posaconazole):来自单中心制度回顾性观测研究的现实数据